Anna Fagotti

18.0k total citations · 2 hit papers
393 papers, 9.0k citations indexed

About

Anna Fagotti is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Anna Fagotti has authored 393 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 252 papers in Reproductive Medicine, 201 papers in Obstetrics and Gynecology and 186 papers in Surgery. Recurrent topics in Anna Fagotti's work include Ovarian cancer diagnosis and treatment (225 papers), Endometrial and Cervical Cancer Treatments (170 papers) and Intraperitoneal and Appendiceal Malignancies (107 papers). Anna Fagotti is often cited by papers focused on Ovarian cancer diagnosis and treatment (225 papers), Endometrial and Cervical Cancer Treatments (170 papers) and Intraperitoneal and Appendiceal Malignancies (107 papers). Anna Fagotti collaborates with scholars based in Italy, Japan and United States. Anna Fagotti's co-authors include Giovanni Scambia, Francesco Fanfani, Valerio Gallotta, Giuseppe Vizzielli, Gabriella Ferrandina, Barbara Costantini, Salvatore Gueli Alletti, Vito Chiàntera, Alfredo Ercoli and Marco Petrillo and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Anna Fagotti

368 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome

2016 276 citations Anna Fagotti, Gabriella Ferrandina et al. profile →
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)

2020 256 citations Anna Fagotti, Maria Gabriella Ferrandina et al. International Journal of Gynecological Cancer profile →

Peers

Countries citing papers authored by Anna Fagotti

Since Specialization

Citations

This map shows the geographic impact of Anna Fagotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Fagotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Fagotti more than expected).

Fields of papers citing papers by Anna Fagotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Fagotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Fagotti. The network helps show where Anna Fagotti may publish in the future.

Co-authorship network of co-authors of Anna Fagotti

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Fagotti. A scholar is included among the top collaborators of Anna Fagotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Fagotti. Anna Fagotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Robotic-assisted uterine transposition for fertility preservation in patients treated with radiotherapy for pelvic malignancies: from transposition to repositioning 2025 ·International Journal of Gynecological Cancer ·Nicolò Bizzarri, Giuditta Chiloiro, (unknown), Matteo Pavone, Inge Peters, Giacomo Corrado, Roberto Persiani, Flavio Tirelli, Maria Antonietta Gambacorta, Anna Fagotti, (unknown), Denis Querleu, Giovanni Scambia	0
2	Image-guided real-time optical biopsy in oncologic surgery: a systematic review of the role of confocal microscopy in the era of digital surgery 2025 ·European Journal of Surgical Oncology ·Matteo Pavone, (unknown), (unknown), (unknown), Maria Chiara Sighinolfi, Camilla Nero, Lise Lecointre, F. Moro, Barbara Costantini, Bernardo Rocco, (unknown), Jacques Marescaux, Barbara Seeliger, Francesco Fanfani, Anna Fagotti, Denis Querleu, Nicolò Bizzarri	0
3	How to Perform Bilateral Sentinel Lymph Node Biopsy in Vulvar Cancer with Indocyanine Green by Video-Endoscopic Approach 2025 ·Annals of Surgical Oncology ·Nicolò Bizzarri, (unknown), (unknown), Simona Maria Fragomeni, Giorgia Garganese, Anna Fagotti, Giovanni Scambia, (unknown)	1
4	Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies: systematic literature review and meta-analysis 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), (unknown), (unknown), Lejla Alić, (unknown), Floris H. P. van Velden, Salvatore Annunziata, Irina Primac, María Ruggiero, (unknown), Evis Sala, Wolfgang P. Fendler, Giovanni Scambia, Lioe‐Fee de Geus‐Oei, Anna Fagotti, Vittoria Rufini, Angela Collarino	0
5	Distribution and prognostic role of BRCA status in elderly ovarian cancer patients 2024 ·Gynecologic Oncology ·Lucia Tortorella, Serena Cappuccio, Diana Giannarelli, Camilla Nero, Cláudia Marchetti, Valerio Gallotta, Barbara Costantini, Tina Pasciuto, Angelo Minucci, Anna Fagotti, Giovanni Scambia	1
6	Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis on Perioperative and Oncologic Outcomes 2024 ·Annals of Surgical Oncology ·Valentina Ghirardi, (unknown), (unknown), Diana Giannarelli, Francesco Santullo, Barbara Costantini, (unknown), Camilla Panico, Luciano Frassanito, Giovanni Scambia, Anna Fagotti	4
7	New windows of surgical opportunity for gynecological cancers in the era of targeted therapies 2024 ·International Journal of Gynecological Cancer ·Inge Peters, Cláudia Marchetti, Giovanni Scambia, Anna Fagotti	4
8	Robotic staging for early ovarian cancer in 10 steps 2024 ·International Journal of Gynecological Cancer ·(unknown), (unknown), Camilla Certelli, (unknown), Anna Fagotti, Giovanni Scambia, Valerio Gallotta	3
9	Consistent data about the predictive factors of the success of interval debulking surgery (CC0-IDS) in patients with advanced ovarian cancers in two large independent datasets. 2024 ·Journal of Clinical Oncology ·Benoît You, Anna Fagotti, Olivier Colomban, Diana Giannarelli, Félix Blanc‐Durand, Giovanni Scambia, (unknown), Domenica Lorusso, Éric Pujade-Lauraine, (unknown), Gaëtan De Rauglaudre, (unknown), Isabelle Laure Ray-Coquard, (unknown), (unknown), (unknown), Gwénaël Ferron, (unknown), Alexandra Léary, Cláudia Marchetti	0
10	#759 Comprehensive cancer genomic profiling in matched primary tumor and brain metastasis samples of ovarian cancer patients: a single-institution case series 2023 ·(unknown), Camilla Nero, Maria De Bonis, Cláudia Marchetti, Angelo Minucci, (unknown), Pier Paolo Mattogno, Alessia Piermattei, Luciano Giacò, Alessandro Olivi, Diana Giannarelli, Anna Fagotti, Giovanni Scambia	1
11	Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 2023 ·International Journal of Gynecological Cancer ·Lucia Musacchio, Serena Maria Boccia, Cláudia Marchetti, Angelo Minucci, Floriana Camarda, Chiara Cassani, Jole Ventriglia, Vanda Salutari, Viola Ghizzoni, Elena Giudice, Maria Teresa Perri, (unknown), Caterina Ricci, Sandro Pignata, Anna Fagotti, Giovanni Scambia, Domenica Lorusso	1
12	Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: Results from the randomised SCORPION trial (NCT01461850) 2023 ·BJOG An International Journal of Obstetrics & Gynaecology ·Cláudia Marchetti, Diana Giannarelli, Giuseppe Vizzielli, (unknown), Lucia Tortorella, Francesco Fanfani, Barbara Costantini, Tina Pasciuto, Giovanni Scambia, Anna Fagotti	7
13	2022-RA-853-ESGO Analysis of the gender distribution among the invited speakers at European society of gynaecological oncology (ESGO) biannual congresses 2017, 2019, and 2021 2022 ·International Journal of Gynecological Cancer ·(unknown), Joanna Kacperczyk‐Bartnik, (unknown), Sara Nasser, (unknown), (unknown), (unknown), (unknown), Nicolò Bizzarri, Philippe Morice, Mansoor Raza Mirza, Anna Fagotti, Nicole Concin	1
14	2022-RA-972-ESGO Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: results from the randomized SCORPION Trial 2022 ·International Journal of Gynecological Cancer ·Cláudia Marchetti, Giovanni Scambia, Diana Giannarelli, Giuseppe Vizzielli, Maria Gabriella Ferrandina, Lucia Tortorella, Francesco Fanfani, Barbara Costantini, Tina Pasciuto, Anna Fagotti	2
15	Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Management of Advanced Ovarian Cancer. A Literature Review 2022 ·European Journal of Gynaecological Oncology ·Valentina Ghirardi, (unknown), Elena Giudice, Giovanni Scambia, Anna Fagotti, Enrique Hernández, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
16	Diagnostic performance of ultrasound in assessing the extension of disease in advanced ovarian cancer 2022 ·American Journal of Obstetrics and Gynecology ·Maria Cristina Moruzzi, (unknown), Rosanna Esposito, F. Mascilini, Francesca Ciccarone, Lorena Quagliozzi, (unknown), (unknown), (unknown), Rossana Moroni, Giovanni Scambia, Anna Fagotti, A. C. Testa, F. Moro	5
17	Simplified anatomical nomenclature of lateral female pelvic spaces 2022 ·International Journal of Gynecological Cancer ·Denis Querleu, Nicolò Bizzarri, Francesco Fanfani, Anna Fagotti, Giovanni Scambia	12
18	Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 2022 ·International Journal of Gynecological Cancer ·Eleonora Palluzzi, Cláudia Marchetti, Serena Cappuccio, Giacomo Avesani, Gabriella Macchia, Maria Antonietta Gambacorta, Fabrizio Cocciolillo, Giovanni Scambia, Anna Fagotti	19
19	Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series 2020 ·Journal of Cancer Research and Clinical Oncology ·Nicolò Bizzarri, Luigi Pedone Anchora, Gabriella Ferrandina, Gian Franco Zannoni, Vittoria Carbone, Camilla Fedele, (unknown), Valerio Gallotta, Salvatore Gueli Alletti, Vito Chiàntera, Anna Fagotti, Giovanni Scambia, Francesco Fanfani	14
20	Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY) 2019 ·American Journal of Obstetrics and Gynecology ·Stefano Uccella, Camilla Nero, Enrico Vizza, Virginia Vargiu, Giacomo Corrado, Nicolò Bizzarri, Fabio Ghezzi, Francesco Cosentino, Luigi Carlo Turco, Anna Fagotti, Giovanni Scambia	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact